These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16923950)

  • 1. 23S rRNA 2058A-->G alteration mediates ketolide resistance in combination with deletion in L22.
    Berisio R; Corti N; Pfister P; Yonath A; Böttger EC
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3816-23. PubMed ID: 16923950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A-->G.
    Pfister P; Corti N; Hobbie S; Bruell C; Zarivach R; Yonath A; Böttger EC
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5180-5. PubMed ID: 15795375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insight into the antibiotic action of telithromycin against resistant mutants.
    Berisio R; Harms J; Schluenzen F; Zarivach R; Hansen HA; Fucini P; Yonath A
    J Bacteriol; 2003 Jul; 185(14):4276-9. PubMed ID: 12837804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA.
    Novotny GW; Jakobsen L; Andersen NM; Poehlsgaard J; Douthwaite S
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3677-83. PubMed ID: 15388419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of resistance to telithromycin in Streptococcus pneumoniae.
    Hisanaga T; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2005 Sep; 56(3):447-50. PubMed ID: 16006449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single and dual mutations at positions 2058, 2503 and 2504 of 23S rRNA and their relationship to resistance to antibiotics that target the large ribosomal subunit.
    Li BB; Wu CM; Wang Y; Shen JZ
    J Antimicrob Chemother; 2011 Sep; 66(9):1983-6. PubMed ID: 21700630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin.
    Davydova N; Streltsov V; Wilce M; Liljas A; Garber M
    J Mol Biol; 2002 Sep; 322(3):635-44. PubMed ID: 12225755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations.
    Farrell DJ; Shackcloth J; Barbadora KA; Green MD
    Antimicrob Agents Chemother; 2006 Feb; 50(2):817-8. PubMed ID: 16436755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding site of the bridged macrolides in the Escherichia coli ribosome.
    Xiong L; Korkhin Y; Mankin AS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of 23S rRNA nucleotide G748 by RlmAII methyltransferase renders Streptococcus pneumoniae telithromycin susceptible.
    Takaya A; Sato Y; Shoji T; Yamamoto T
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3789-96. PubMed ID: 23716046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection for high-level telithromycin resistance in Staphylococcus aureus yields mutants resulting from an rplB-to-rplV gene conversion-like event.
    Gentry DR; Holmes DJ
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1156-8. PubMed ID: 18195060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.
    Pereyre S; Métifiot M; Cazanave C; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Int J Antimicrob Agents; 2007 Feb; 29(2):207-11. PubMed ID: 17196370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.